Article info

Download PDFPDF
Novel patient-specific visual analogue survey (PVS) is validated in patients treated with collagenase injection for Dupuytren’s disease

Authors

  1. Correspondence to Dr Stephen L Lyman, Healthcare Research Institute, Hospital for Special Surgery, New York, NY 10021, USA; lymans{at}hss.edu
View Full Text

Citation

Lyman SL, Burket Kotsov J, Hidaka C, et al
Novel patient-specific visual analogue survey (PVS) is validated in patients treated with collagenase injection for Dupuytren’s disease

Publication history

  • Accepted August 11, 2019
  • First published November 14, 2019.
Online issue publication 
January 29, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.